News | CT Angiography (CTA) | September 17, 2019

New ESC Guideline Provides Class 1 Recommendation for Coronary CTA

Continuation of 2013 guidelines recommends coronary CT angiography as initial test to rule out or establish diagnosis of chronic coronary syndromes

New ESC Guideline Provides Class 1 Recommendation for Coronary CTA

September 17, 2019 — The European Society of Cardiology (ESC) published new guidelines on the diagnosis and management of chronic coronary syndromes (CCS), which classifies computed tomography angiography (CTA) as a Class 1 recommendation for diagnosing CAD in symptomatic patients. The document, which is a continuation of the 2013 stable coronary artery disease (CAD) guidelines, updates the term to CCS to emphasize the dynamic nature of the disease. It was released at the 2019 ESC Congress, Aug. 31-Sept. 4 in Paris, France, and published simultaneously in the European Heart Journal.1 

Per the guideline, unless obstructive CAD can be excluded based on clinical evaluation alone, either non-invasive functional imaging or anatomical imaging using coronary CTA should be used as the initial test to rule out or establish the diagnosis of CCS.

The new guideline suggests that "Coronary CTA is the preferred test in patients with a lower range of clinical likelihood of CAD, no previous diagnosis of CAD and characteristics associated with a high likelihood of good image quality."

“Depending on patient characteristics, local expertise and availability, as well as patient-specific considerations, physicians should decide between coronary CTA and ischemia testing,” said ESC President-elect Stephan Achenbach, M.D., FSCCT. “This is a recognition of the numerous trials that have been performed to establish the usefulness and reliability of CT angiography as a first-line examination."

“The guideline recommendations are based on data that shows that the use of coronary CTA leads to accurate identification of coronary artery disease, which if treated appropriately, can lead to improved patient outcomes.” added Ron Blankstein, M.D., FSCCT, president of SCCT. “The guidelines recognize that there are multiple factors that should be used in test selection, but that for many, a coronary CTA-first approach is beneficial.”

The guidelines also place stronger emphasis on lifestyle behaviors, and for the first time, address the negative impact of pollution and noise on CCS patients. Additionally, an annual flu vaccination, particularly for elderly patients, is recommended, as is behavioral counseling.

For more information: www.academic.oup.com/eurheartj

 

Reference

1. Knuuti J., Wijns W., Saraste A., et al. 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes: The Task Force for the diagnosis and management of chronic coronary syndromes of the European Society of Cardiology (ESC). European Heart Journal, published online Aug. 31, 2019. https://doi.org/10.1093/eurheartj/ehz425

Related Content

The Caption Guidance software uses artificial intelligence to guide users to get optimal cardiac ultrasound images in a point of care ultrasound (POCUS) setting.

The Caption Guidance software uses artificial intelligence to guide users to get optimal cardiac ultrasound images in a point of care ultrasound (POCUS) setting.

News | Artificial Intelligence | February 13, 2020
February 13, 2020 — The U.S.
A patient-specific airway stents developed by Cleveland Clinic physician Tom Gildea, M.D. 

A patient-specific airway stents developed by Cleveland Clinic physician Tom Gildea, M.D. 

News | Computed Tomography (CT) | February 10, 2020
February 10, 2020 — The U.S.
This is a lung X-ray reviewed automatically by artificial intelligence (AI) to identify a collapsed lung (pneumothorax) in the color coded area. This AI app from Lunit is awaiting final FDA review and in planned to be integrated into several vendors' mobile digital radiography (DR) systems. Fujifilm showed this software integrated as a work-in-progress into its mobile X-ray system at RSNA 2019. GE Healthcare has its own version of this software for its mobile r=ray systems that gained FDA in 2019.   #RSNA #

This is a lung X-ray reviewed automatically by artificial intelligence (AI) to identify a collapsed lung (pneumothorax) in the color coded area. This AI app from Lunit is awaiting final FDA review and in planned to be integrated into several vendors' mobile digital radiography (DR) systems. Fujifilm showed this software integrated as a work-in-progress into its mobile X-ray system at RSNA 2019. GE Healthcare has its own version of this software for its mobile r=ray systems that gained FDA in 2019.

Feature | RSNA | January 20, 2020 | Dave Fornell, Editor
Here are images of some of the newest new medical imaging technologies displayed on the expo floor at the ...